Reconstitution of G1 cyclin ubiquitination with complexes containing SCF(Grr1) and Rbx1

Science

Volumn 284, Issue 5414, 1999, Pages 662-665

  Skowyra, Dorota ^a   Koepp, Deanna M ^a   Kamura, Takumi ^b   Conrad, Michael N ^b   Conaway, Ronald C ^b   Conaway, Joan Weliky ^b,c   Elledge, Stephen J ^a   Harper, J Wade ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLINE; PROTEIN RBX1; PROTEIN SCF; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ANAPHASE PROMOTING COMPLEX; ANAPHASE-PROMOTING COMPLEX; CARRIER PROTEIN; CDC53 PROTEIN, S CEREVISIAE; CELL CYCLE PROTEIN; CLN1 PROTEIN, YEAST; CULLIN; FUNGAL PROTEIN; GRR1 PROTEIN, S CEREVISIAE; HYBRID PROTEIN; LIGASE; PEPTIDE SYNTHASE; S PHASE KINASE ASSOCIATED PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; COMPLEX FORMATION; ENZYME RECONSTITUTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CULLIN PROTEINS; CYCLINS; FUNGAL PROTEINS; LIGASES; MOLECULAR SEQUENCE DATA; PEPTIDE SYNTHASES; PHOSPHORYLATION; RECOMBINANT FUSION PROTEINS; S-PHASE KINASE-ASSOCIATED PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE ALIGNMENT; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN-PROTEIN LIGASE COMPLEXES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 0033596977     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5414.662     Document Type: Article

References (36)

1. D. O. Morgan, Annu. Rev. Cell Dev. Biol. 13, 261 (1997).
2. J. A. Diehl, F. Zindy, C. J. Sherr, Genes Dev. 11, 957 (1997).
3. B. E. Clurman, R. J. Sheaff, K. Thress, M. Groudine, J. M. Roberts, ibid. 10, 1979 (1996).
4. K.-A. Won and S. I. Reed, EMBO J. 15, 4182 (1996).
5. S. Lanker, M. H. Valdivieso, C. Wittenberg, Science 271, 1597 (1996).
6. C. Bai et al., Cell 86, 263 (1996).
7. A. R. Willems et al., ibid., p. 453.
8. R. J. Deshaies, V. Chau, M. Kirschner, EMBO J. 14, 303 (1995).
9. Y. Barral, S. Jentsch, C. Mann, Genes Dev. 9, 399 (1995).
10. B. L. Schneider et al., Nature 395, 86 (1998).
11. N. Mathias et al., Mol. Cell. Biol. 16, 6634 (1996).
12. D. K. Skowyra, K. Craig, M. Tyers, S. J. Elledge, J. W. Harper, Cell 91, 209 (1997).
13. Yeast extracts from isogenic YM4575 (GRR1) or YM4576 (grr1Δ) strains (32) or CB018 (pep4::HIS3) were fractionated on DEAE-Sephacryl (33). Proteins editing with 250 and 500 mM KCl were collected (F250 and F500, respectively). Immunoblot analysis revealed Cdc34 only in the F500 fraction. Twenty-microliter ubiquitination reactions (30 to 60 min, 25°C) contained 500 nM Cdc34, 300 nM E1, 2 mM adenosine triphosphate (ATP), an ATP-regenerating system, 20 μM ubiquitin, 0 to 120 μg of F250, and 50 ng of active or kinase-defective (K-) HA-Cln1/GST-Cdc28 (12). Cln1 autophosphorylation was performed at 25°C in the presence of 1 mM ATP for 30 min. Reaction mixtures were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and products were visualized by immunoblotting with ECL detection (Amersham). SCF complexes were purified from insect cells 40 hours after infection with antibodies to tagged proteins (12). A baculovirus encoding untagged Grr1 (in pVL1392) was produced with Baculogold (Pharmingen). Rabbit anti-Grr1 was generated with the peptide MDQDNNNHND-SNRL (see legend to Fig. 4 for amino acid abbreviations). RBX1 and rbx1-1 (16) extracts were prepared from cells shifted to 38°C for 16 hours. Strains (MATa RBX1::HIS3 ura3 leu2 trp1 lys2 his3Δ200 can1-100 cyh2) were maintained by a plasmid containing either a wild-type (pDK101) or mutant (pDK102) version of RBX1 in pRS314.
14. D. K. Skowyra, D. M. Koepp, S. J. Elledge, J. W. Harper, unpublished data.
15. T. Kamura et al., Science 284, 657 (1999).
16. RBX1 was disrupted by inserting the LEU2 gene into the Nsi I site in the RBX1 open reading frame in pDK100 (containing a genomic RBX1 fragment in pRS316). A Sac I-Sph I fragment from pDK100 was used to transform Y80 (MATa can1-100 ade2-1 his3-11, 15 leu 2-3, 112 trp1-1 ura3-1) carrying pDK100 to generate the disruption strain. Strains that could not grow without pDK100 were chosen, and integration of the LEU2 gene was confirmed by Southern (DNA) blot analysis. The rbx1-1 allele was generated by polymerase chain reaction mutagenesis (34) with primers flanking the open reading frame. The plasmid was rescued from a temperature-sensitive strain, retested, and sequenced.
17. C. Connelly and P. Hieter, Cell 86, 275 (1996).
18. Baculoviruses encoding Rbx1 and MYC3-Rbx1 [in pVL1392 or pHI-100 by universal plasmid subcloning (35), respectively] were generated with Baculogold (Pharmingen).
19. RA), and 50 ng of HA-Cln1/GST-Cdc28. Reaction mixtures were separated by SDS-PAGE and immunoblotted.
20. A. Banerjee, L. Gregori, Y. Xu, V. Chau, J. Biol. Chem. 268, 5668 (1993).
21. F250 (1 mg) was fractionated over a Superdex 200 column (Pharmacia) in 50 mM tris-HCl (pH 7.5), 50 mM KCL Pools of four fractions (0.25 ml each) were concentrated with Centricon-10 and samples (50 μg of protein) were used for assays (13).
22. M. Goebl, personal communication.
23. W. Zachariae et al., Science 279, 1216 (1998).
24. R. Y. Hampton, R. G. Gardner, J. Rine, Mol. Biol. Cell 7, 2029 (1996).
25. H. Huang, A. Kahana, D. E. Gottschling, L. Prakash, S. W. Liebman, ibid. 17, 6693 (1997).
26. B. Bartel, I. Wunning, A. Varshavsky, EMBO J. 9, 3179 (1990).
27. V. Bailly, S. Lauder, S. Prakash, L. Prakash, J. Biol. Chem. 272, 23360 (1997).
28. V. Bailly, S. Prakash, L. Prakash, Mol. Cell. Biol. 17, 4536 (1997).
29. R. J. Dohmen, K. Madura K. B. Bartel, A. Varshavsky, Proc. Natl. Acad. Sci. U.S.A. 88, 7351 (1991).
30. T. Potuschak et al., ibid. 95, 7904 (1998).
31. R. Honda, H. Tanaka, H. Yasuda, FEBS Lett. 420, 25 (1997).
32. J. S. Flick and M. Johnston, Mol. Cell. Biol. 11, 5101 (1991).
33. R. J. Deshales and M. Kirschner, Proc. Natl. Acad. Sci. U.S.A. 92, 1182 (1995).
34. M. S. Lee, M. Henery, P. Silver, Genes Dev. 10, 1233. (1996).
35. Q. Liu, M. Z. Li, D. Leibham, D. Cortez, S. J. Elledge, Curr. Biol. 8, 1300 (1998).
36. We thank M. Goebl for anti-Cdc34 and discussions, M. Tyers for Cdc53, M. Johnson for strains, C. Correll and R. Deshaies for HA-Grr1, and M. Li and P. Sen for technical assistance. Supported by NIH grants AG11085 (to J.W.H. and S.J.E.), GM54137 (to J.W.H.), GM41628 (to R.C.C.), the Welch Foundation (J.W.H), the H. A. and Mary K. Chapman Charitable Trust (J.W.C), and the Helen Hay Whitney Foundation (D.M.K). S.J.E. and J.W.C are Investigators with the Howard Hughes Medical Institute.